Pre-MENACTRIMS Symposium Merck Medical Grand Rounds
MS over time: Milestones, decisions, and perspectives
Merck Medical Grand Rounds is an award-winning programme dedicated to case study discussion, reflecting the format of a hospital grand rounds, to create interactive dialogue around the practical management of patients.
Join the conversation as leading experts navigate key milestones in MS management across the patient lifespan, and explore how treatment decisions made today can influence future outcomes for people living with MS.
- Time
- 17:45–18:45
- Date
- December 3, 2026
- Venue
-
Al Baraha 1, Intercontinental Hotel Festival City
Dubai, United Arab Emirates
Program
| Time (GST) | MS over time: Milestones, decisions, and perspectives |
| 17:45–17:55 |
The age-old question: How should future priorities influence decisions today? All speakers, moderated by Gavin Giovannoni (UK), Chair |
| 17:55–18:10 |
The first decision: Regional perspectives on the newly diagnosed patient Gavin Giovannoni; Raed Alroughani (KWT) |
| 18:10–18:25 |
Planning for life events: Managing MS and pregnancy across regions Kerstin Hellwig (GER); Raed Alroughani |
| 18:25–18:40 |
Revisiting the patient: The long-term view Bassem Yamout (UAE) |
| 18:40–18:45 |
Audience Q&A and meeting close All speakers, moderated by Gavin Giovannoni |
Faculty
Blizard Institute, Barts & The
London School of Medicine
and Dentistry
Director of MS Clinic
Amiri and Ibn Sina Hospitals
St. Josef Hospital & Ruhr University
Director Neurology Institute
American University of Beirut
& Harley Street Medical Center
Emirates
Target Audience
- Specialists
- Neurologists
- Practitioners
- Researchers in the field of MS
Registration
Registration is complimentary. The Merck Medical Grand Rounds content is developed for healthcare professionals.
GL-NONNI-02782 | September 2026
This is an international medical and scientific symposium organized and hosted by Merck. It will be delivered in English and is intended for an international audience of qualified healthcare professionals. Prescribing information may vary depending on local approval in each country. Therefore, before prescribing any product always refer to locally approved prescribing information and/or the Summary of Product Characteristics (SmPC). For the European Medicines Agency approved SmPC, please access: https://www.ema.europa.eu © 2026 Merck KGaA, Darmstadt, Germany, and/or its affiliates. All rights reserved.
Neurology Institute
American University of Beirut,
Harley Street Medical Centre
